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Bioenergetic metabolism varies during cell differenti-
ation, but details of B cell metabolism remain un-
clear. Here, we show the metabolic changes during
B cell differentiation in the intestine, where B cells
differentiate into IgA+ plasma cells (PCs). Naive B
cells in the Peyer’s patches (PPs) and IgA+ PCs in
the intestinal lamina propria (iLP) both used the
tricarboxylic acid (TCA) cycle, but only IgA+ PCs
underwent glycolysis. These metabolic differences
reflected their dependencies on vitamin B1, an
essential cofactor for the TCA cycle. Indeed, the
diminished activity of the TCA cycle after dietary
vitamin B1 depletion decreased the number of naive
B cells in PPs without affecting IgA+ PCs in the iLP.
The maintenance of naive B cells by dietary vitamin
B1 was required to induce—but not maintain—intes-
tinal IgA responses against oral antigens. These
findings reveal the diet-mediated maintenance of B
cell immunometabolism in organized and diffuse
intestinal tissues.122 Cell Reports 13, 122–131, October 6, 2015 ª2015 The AuthorsINTRODUCTION
In general, cells are capable of breaking down large molecules
(e.g., proteins, lipids, and sugars) into small ones (e.g., amino
acids, fatty acids, and monosaccharides) and of constructing
large molecules from small units. In the catabolism of
sugars, fats, and proteins, their metabolites are incorporated
into the tricarboxylic acid (TCA) cycle, a series of biochemical
reactions leading ultimately to the generation of ATP. Unlike
the catabolic pathways of proteins and lipids, glycolysis itself
also generates ATP. The regulation of cellular metabolism by
achieving a balance between catabolism and anabolism is a
key to the maintenance of appropriate cellular responses and
function.
Recently, much attention has been paid to the concept
of ‘‘immunometabolism.’’ Immunometabolism comprises two
components: immune responses mediated by whole-body
metabolism (e.g., obesity and diabetes) (Mathis and Shoelson,
2011) and various metabolic pathways within immune cells
(Pearce and Pearce, 2013). Accumulating evidence regarding
immune cells has revealed that their metabolism changes during
development, activation, and differentiation, as has been well
documented in T cells (Pearce et al., 2013; Wang and Green,
2012). In general, T cell activation (e.g., via T cell receptor and
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Figure 1. Metabolites Generated in Naive B
Cells in PPs and IgA+ PCs in the iLP
(A) Small intestinal tissues, including PPs and
iLP, underwent H&E staining and MALDI-IMS for
the detection of citrate, malate, glucose mono-
phosphate (Glc monoP), and fructose-bi-phos-
phate (FBP). The results shown are representative
of three independent experiments. Scale bars
indicate 300 mm.
(B and C) Naive B cells and IgA+ PCs were
purified from PPs and iLP, respectively. CE-MS
quantification of metabolites from glycolysis (Glc
monoP and FBP) and the TCA cycle (citrate,
succinate, fumarate, and malate) in purified naive
B cells and IgA+ PCs (B). Data are given as
means ± 1 SD (n = 11). (C) The relative amounts
of glycolysis- (Glc monoP and FBP) and TCA-
cycle-intermediate metabolites (citrate, succinate,
fumarate, and malate) in naive B cells (Naive)
and IgA+ PCs (PC). The data shown are averages
(n = 4) and are representative of three indepen-
dent experiments.
See also Figure S1.CD28) is associated with increased glucose uptake and glycol-
ysis (Fox et al., 2005; Frauwirth et al., 2002). In addition, among
effector T cells, Th1, Th2, and Th17 cells utilize glycolytic path-
ways, but regulatory T (Treg) cells use lipid oxidation (Michalek
et al., 2011). Similarly, lipid oxidation and mitochondrial respira-
tory capacity are important factors in the development of mem-
ory CD8+ T cells (Pearce et al., 2009; van der Windt et al., 2012,
2013). In addition to T cells, other immune cells (e.g., macro-
phages and dendritic cells) demonstrate various features of im-
munometabolism to exert their immune functions (Everts et al.,
2014; O’Neill and Hardie, 2013); however, little is known about
bioenergeticmetabolism in B cells, especially terminally differen-
tiated antibody-producing plasma cells (PCs).
In this study, we focused on the intestinal immune system.
Unlike that in other immune compartments (e.g., spleen, lymph
nodes, lung, and skin), immunologic activation in the intestine
occurs spontaneously due to continuous stimulation from intes-
tinal environmental antigens (e.g., commensal bacteria and die-
tary materials) (Hooper et al., 2012; Spencer and Belkaid, 2012).
Therefore, terminally differentiated IgA+ PCs are abundantly pre-
sent in the intestinal lamina propria (iLP) (Cerutti et al., 2011;
Pabst, 2012). Another important immunologic site in the intestine
is Peyer’s patches (PPs). PPs are the primary gut-associated
lymphoid tissue, where naive B cells predominate and where
unique immunologic crosstalk by cytokines (e.g., IL-4 and trans-
forming growth factor-b [TGF-b]) and cell-cell interactions (e.g.,
CD40L) induce immunoglobulin class switching from IgM to
IgA to initiate intestinal IgA responses against intestinal antigen
(Kunisawa et al., 2012b). These immunologic features allow us
to compare in vivo energy metabolism between naive B cells inCell Reports 13, 122–13the PPs and terminally differentiated
IgA+ PCs in the iLP. Here, we identified
changes in immunometabolism during B
cell differentiation into IgA+ PCs in the in-
testine. Furthermore, we showed that themetabolic differences between naive B cells in the PPs and IgA+
PCs in the iLP were associated with distinct dependencies on
vitamin B1, an essential cofactor for the TCA cycle. The require-
ment for dietary vitamin B1 was pivotal for the induction of intes-
tinal IgA responses against oral vaccine.
RESULTS
Naive B Cells in the PPs and IgA+ PCs in the iLP Produce
Different Metabolites
We initially used matrix-assisted laser desorption-ionization im-
aging-mass spectrometry (MALDI–IMS) to visualize the in vivo
distribution of metabolites in the intestine (Sugiura et al., 2011).
Signals associated with citrate and malate, representative
metabolites generated through the TCA cycle, were similar
between PPs and iLP, whereas metabolic intermediates of
glycolysis (e.g., glucosemono-phosphate [Glc monoP] and fruc-
tose bis-phosphate [FBP]) were detected preferentially in iLP
(Figure 1A).
Because PPs and iLP contain various types of immune cells,
we next aimed to measure the metabolites in purified cells
ex vivo. We purified naive B cells and IgA+ PCs from the PPs
and iLP, respectively, and used capillary electrophoresis-mass
spectrometry (CE-MS) metabolomics to comprehensively mea-
sure theirmetabolites (Sugiura et al., 2011). Consistentwith in vivo
MALDI-IMS results, the amounts of Glc monoP and FBP were
higher in IgA+ PCs than in naive B cells (Figure 1B). In line with
this, concentrations of metabolites representative of the early
phase of the TCA cycle (e.g., citrate and succinate) were identical
between naive B cells and IgA+ PCs, but those indicative of the1, October 6, 2015 ª2015 The Authors 123
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Malate Figure 2. Different Metabolic Pathways be-
tween Naive B Cells and IgA+ PCs in the
Intestine
(A) Naive B cells and IgA+ PCs were purified from
PPs and iLP, respectively, for the analysis of
glucose uptake (n = 8).
(B) Purified naive B cells and in vitro-differentiated
IgA+ cells were treated with 13C6-glucose and used
for the measurement of 13C-labeled FBP and
malate (n = 3).
(C–E) Naive B cells and IgA+ PCs were purified
from PPs and iLP, respectively. Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) activity (C)
(n = 8), expression of mRNAs encoding aconitase 2
(Aco2) and 2-oxoglutarate dehydrogenase (OGDH)
(D) (n = 4), and succinate dehydrogenase activity (E)
(n = 4) were compared between naive B cells (naive)
and IgA+ PCs (PC). Data are given as means ± 1 SD
and are representative of at least two independent
experiments.
(F and G) Purified naive B [left in (F) and (G)] and
IgA+ PCs [right in (F)] were treated with vehicle only
(mock), rotenone (Rot), or oligomycin (Oligo) for
20 hr, after which cells were counted (F) or evalu-
ated as apoptosis (G) (n = 4). Data are given as
means ± 1 SD and are representative of three in-
dependent experiments.
See also Figure S2.late phase of the TCA cycle (e.g., fumarate and malate) were
higher in naive B cells than in IgA+ PCs (Figure 1B). Therefore,
the composition ofmetabolites from glycolysis and the TCA cycle
differed between naive B cells and IgA+ PCs (Figure 1C).
We next examined whether this metabolic profile in B cells
was specific to intestinal B cells or a general phenomenon inde-
pendent of anatomic localization. To this end, we measured me-
tabolites in naive B cells, CD93+ CD138+ short-lived PCs, and
CD93 CD138+ long-lived PCs derived from the spleen. Like
naive B cells and IgA+ PCs in the intestine, these splenic popu-
lations showed identical levels of metabolites from the TCA cy-
cle (Figure S1), but none of the splenic cells had detectable
levels of glycolytic metabolites (e.g., Glc monoP and FBP).
Therefore, the generation of glycolytic metabolites was unique
to in the intestinal IgA+ PCs and may reflect features of their
unique immunologic environment, such as continuous exposure
to commensal bacteria and consequent spontaneous produc-
tion of cytokines.124 Cell Reports 13, 122–131, October 6, 2015 ª2015 The AuthorsNaive B Cells and IgA+ PCs in the
Intestine Have Distinct Metabolic
Pathways
Our findings obtained from MALDI-IMS
and CE-MS analyses suggested that
glycolysis was used preferentially by IgA+
PCs in the iLP but not by naive B cells in
the PPs. This idea is supported by a result
showing that the efficacy of glucose up-
take was higher in IgA+ PCs than in naive
B cells (Figure 2A). Because the pool size
of each metabolite does not correlate
with flux through metabolic pathways, weperformed metabolic-pathway tracing analysis using a stable
isotope tracer, 13C-labeled glucose. Consistent with our current
findings, naive B cells lacked detectable signal derived from
13C-labeled glucose due to their low efficacy of glucose uptake
(Figure 2B). In contrast, in vitro differentiated IgA+ PCs showed
signals from 13C-labeled FBP and malate (Figure 2B).
Pyruvate, a glycolytic metabolite, leads to either lactate, which
does not enter the TCA cycle, or to acetyl-CoA, which subse-
quently enters the TCA cycle. In this context, we detected a
weak lactate-associated signal in both the PPs and iLP (Fig-
ure S2A). In addition, pathway tracing using 13C-labeled glucose
demonstrated that 13C-glucose was predominantly metabolized
into glutamate through the TCA cycle (Figure S2B), suggesting
that the pyruvate generated by IgA+ PCs through glycolysis en-
ters the TCA cycle rather than forms lactate.
In agreement with these findings, the enzymatic activity of
glyceraldehyde 3-phosphate dehydrogenase, a key enzyme in
glycolysis,washigher in IgA+PCs than innaiveBcells (Figure 2C).
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Figure 3. Impaired TCA Cycle by Depletion of Dietary Vitamin B1
(A) Mice were maintained on vitamin B1(+) or vitamin B1() diet. The concentration of vitamin B1 in feces, small intestine, and serum was measured on days 7, 14,
and 21. The data represent the means ± 1 SD (n = 3 to 8).
(B–D) After maintenance of mice on vitamin B1(+) or vitamin B1() diet for 21 days, CE–MS (B) andMALDI-IMS (C) of intestinal tissues were performed tomeasure
citrate and Glc monoP (B and C). Scale bars indicate 300 mm. Energy charge in the PPs and iLP was calculated from the amounts of ATP, ADP, and AMP (D). The
data represent means ± 1 SD (n = 8) and are representative of three independent experiments.In contrast to those of the glycolytic pathway, the expression of
key enzymes related to the TCA cycle (aconitase 2 [Aco2], 2-ox-
oglutarate dehydrogenase [OGDH], and succinate dehydroge-
nase) was similar between naive B cells and IgA+ PCs (Figures
2D and 2E).
Our current findings collectively suggest that IgA+ PCs in the
iLP obtain energy (ATP) from both glycolysis and the TCA cycle,
whereas naive B cells in the PPs preferentially use the TCA cycle,
initiated by the non-glycolytic pathway, for energy generation.
Therefore, we considered it possible that inhibition of the TCA
cycle would have different effects on naive B cells and IgA+
PCs. To test this hypothesis, we used rotenone to inhibit
mitochondrial respiratory chain complex I and thus impair ATP
generation via the TCA cycle (Barrientos and Moraes, 1999).
In vitro treatment with rotenone decreased the number of naive
B cells but not of IgA+ PCs (Figure 2F). Under this condition, cells
did not proliferate; therefore, the reduction in the number of naive
B cells was due to increased cell death. Indeed, rotenone treat-
ment resulted in increased numbers of annexin V+ apoptotic cells
(Figure 2G). Similarly, the number of naive B cells but not of IgA+
PCs was selectively reduced with an increase in apoptotic cells
when ATP generation from the TCA cycle was inhibited by treat-
ing cells with oligomycin, an inhibitor of mitochondrial ATPase
(Chappell and Greville, 1961) (Figures 2F and 2G). These findings
collectively imply that naive B cells obtain ATP predominantlyCthrough the TCA cycle, whereas IgA+ PCs use both glycolysis
and the TCA cycle to generate ATP.
Depletion of Dietary Vitamin B1 Inhibits the TCA Cycle
without Affecting Glycolysis In Vivo
Our in vitro analysis indicated that inhibition of the TCA cycle re-
sulted in the selective reduction of naive B cells. To confirm the
effect of TCA cycle inhibition in vivo, we focused on vitamin B1,
an essential cofactor that is specifically required for the enzy-
matic activity of OGDH and pyruvate dehydrogenase, essential
enzymes in the TCA cycle (Frank et al., 2007). Because vitamin
B1 is synthesized in bacteria, protozoans, fungi, and plants but
not in mammals, mammalian species must obtain vitamin B1
from their diets (Webb et al., 2007). This feature allowed us to
examine the in vivo effects of vitamin B1-mediated maintenance
of the TCA cycle in mice fed a vitamin B1-deficient diet (vitamin
B1[] mice). Depletion of dietary vitamin B1 was associated
with a rapid decrease in fecal vitamin B1 levels and a consequent
gradual reduction of those in the small intestine (Figure 3A).
In contrast to the intestine, serum vitamin B1 levels tended to
be maintained but ultimately showed a statistically significant
decrease after 21 days of dietary vitamin B1 depletion (Figure 3A;
control: 503.3 ± 50.6; vitamin B1[]: 318.0 ± 17.7; p = 0.029).
As expected, intestinal cells of vitamin B1() mice showed
selective impairment of the TCA cycle. Indeed, CE-MS andell Reports 13, 122–131, October 6, 2015 ª2015 The Authors 125
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Figure 4. Reduction of Naive B Cells and Lymphoid Tissues in the PPs but Normal Numbers and Function of IgA+ PCs in the iLP after
Depletion of Dietary Vitamin B1
Mice were maintained on vitamin (Vit) B1(+) or Vit B1() diet for 21 days.
(A) The number of visible PPs was examined. The data are given as means ± 1 SD (n = 8).
(B) H&E staining (left) and immunostaining of PPs with B220 and CD4 were performed for histologic analyses. Scale bars indicate 300 mm.
(C) Naive B cells in the PPs were counted. The data are given as means ± 1 SD (n = 8).
(D and E) Mononuclear cells were isolated from the iLP for analysis of the frequency (D) and number (E) of IgA+ PCs. The data are given as means ± 1 SD (n = 7).
(F) The distribution of IgA+ PCs in the iLP was examined by fluorescence microscopy. Scale bars indicate 100 mm.
(G) Fecal extracts were obtained for the measurement of IgA amounts by ELISA. The data are given as means ± 1 SD (n = 7).
See also Figures S3, S4, and S5.MALDI-IMS revealed decreases in TCA cycle metabolites (e.g.,
citrate) with little effect on glycolytic metabolites (e.g., Glc mo-
noP) in the intestine of vitamin B1() mice (Figures 3B and 3C).
These effects were associated with a decreased energy charge,
an indicator of cellular energy status that is calculated from the
concentrations of ATP, ADP, and AMP (Atkinson, 1968) in the
vitamin B1() mice (Figure 3D).
The Impaired TCA Cycle due to Vitamin B1 Deficiency
Leads to Decreased Numbers of Naive B Cells and
Consequent Atrophy of PPs with Little Effect on IgA+
PCs in the iLP
We typically saw seven to ten PPs in the small intestine of mice
fed a vitamin-B1-sufficient diet (vitamin B1[+] mice), whereas few
(if any) PPs were discernible in vitamin B1() mice; therefore the
number of visible PPs was decreased in vitamin B1() mice (Fig-
ure 4A). In addition, the reduction in the size and number of PPs
in vitamin B1() mice was accompanied by decreases in the size
of B cell follicles and in the number of naive B cells with little ef-
fect on T cells (Figures 4B, 4C, and S3A). We next examined the
effect of dietary vitamin B1 depletion on bone marrow cells,
revealing the reduction of pre/pro-B cells (Figure S3B). There-
fore, the recruitment of naive B cells from bone marrow was
reduced, which explained, at least partly, the decrease in the
number of naive B cells in the periphery.126 Cell Reports 13, 122–131, October 6, 2015 ª2015 The AuthorsAs occurred with PPs, other lymphoid tissues including
spleen and mesenteric lymph nodes were smaller in vitamin
B1() than in control mice (Figure S4). We then investigated
whether the effect of vitamin B1 depletion was reversible. To
address this issue, vitamin B1() diet was replaced with vitamin
B1(+) diet after a 21-day depletion of dietary vitamin B1. PPs,
spleen, and mesenteric lymph nodes all recovered in size by
14 days after the switch to the vitamin B1(+) diet (Figure S4),
suggesting that the lymphoid atrophy induced by vitamin B1
deficiency was reversible.
We next examined IgA+ PCs in the iLP of vitamin B1() mice.
Unlike naive B cells in the PPs, IgA B220 PCs in the iLP of
vitamin B1() mice were unchanged in frequency and absolute
cell number when compared with those of vitamin B1(+) mice
(Figures 4D and 4E). Fluorescent microscopic analysis further
confirmed that IgA+ PCs were distributed normally in the iLP of
vitamin B1() mice (Figure 4F). We then examined whether these
PCs were functionally normal and produced IgA in the absence
of vitamin B1 in vivo. The amount of total IgA in the feces was
comparable between vitamin B1(+) and vitamin B1() mice (Fig-
ure 4G). These findings indicated a change in B cell homeostasis
in the vitamin B1-deficient condition. To address this issue, we
performed a BrdU uptake assay, showing that the number of
BrdU+ IgA+ cells decreased rapidly in the vitamin B1() mice
when compared with the vitamin B1(+) mice (Figure S5),
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Figure 5. VitaminB1 Transporter Expression
on Naive B cells in the PPs and on IgA+ PCs
in the iLP
(A) qRT-PCR was performed to measure the gene
expression of THTR1 and THTR2 in the naive B
cells in the PPs (naive) and IgA+ PCs in the iLP (PC).
Data are given as means ± 1 SD (n = 7).
(B) PPs were immunostained for B220 and THTR1;
iLP was stained with IgA and THTR1. The data
shown are representative of three independent
experiments.
(C and D) Naive B cells or IgA+ PCs were cultured
with different concentrations of oxythiamine for
3 days. Cell numbers of both populations (C) and
viability of naive B cells (D) were then determined.
Data are given as means ± 1 SD (n = 4) and are
representative of two independent experiments.
(E) Naive B cells labeled with carboxyfluorescein
succinimidyl ester (CFSE) andculturedwithdifferent
concentrations of oxythiamine in the presence of
LPS for 3 days. The CFSE-associated signal was
determined by flow cytometry. Data are given as
means ± 1 SD (n = 4) and are representative of two
independent experiments.presumably due to the decreased supply of BrdU+ IgA+ cells
from the PPs. These findings collectively indicate that the depen-
dency on vitamin B1 differed between naive B cells and IgA
+ PCs
and that, unlike naive B cells, IgA PCs in the iLP were sufficient in
number and function to produce IgA in the absence of vitamin B1.
The Expression Levels of Vitamin B1 Transporters in B
cells and IgA+ PCs Are Consistent with Their Vitamin B1
Dependency
The differing dependencies of naive B cells and IgA+ PCs on
vitamin B1 led us to examine the expression of vitamin B1 trans-
porters, which mediate the active transport of vitamin B1 into
the intracellular compartment. Regarding the vitamin B1 trans-
porters thiamine transporter 1 and 2 (THTR1 and THTR2) (Dutta
et al., 1999; Rajgopal et al., 2001), qPCR analysis showed that
THTR1, but not THTR2, was expressed in both naive B cells and
IgA+ PCs and that the THTR1 level was higher in the naive B cells
than in IgAPCs (Figure5A). Immunostaining furtherconfirmed that
the majority of the population of naive B cells expressed THTR1,
whereas only occasional IgA+ PCs expressed this transporter
(Figure5B). Thesefindingssuggest that distinct vitaminB1depen-
dencies of naive B cells and IgA+ PCs were consistent with their
expression levels of vitamin B1 transporters, especially THTR1.Cell Reports 13, 122–13These findings led us to examine
whether vitamin B1 depletion directly
affected B cells. To address this issue,
we performed in vitro analysis using puri-
fied B cells. Treatment with vitamin B1
antagonist (oxythiamine) decreased the
number and viability of naive B cells,
whereas cell numbers of IgA+ PCs were
unchanged (Figures 5C and 5D). We also
found that oxythiamine inhibited LPS-
induced proliferation of purified naive Bcells (Figure 5E). Therefore, although we cannot exclude the
possible involvement of other cells, vitamin B1 depletion has a
direct effect on the survival and proliferation of B cells.
Vitamin B1-Dependent Maintenance of Naive B Cells Is
Required for the Induction but Not Maintenance of
Intestinal IgA Responses against Orally Immunized
Antigen
We wondered whether the different dependencies on vitamin
B1 during B cell differentiation in the intestine affected the in-
duction of antigen-specific IgA responses against orally admin-
istered antigen. In this experiment, groups of mice were main-
tained on the control (vitamin B1[+]) diet throughout the 31-day
experimental period (controls), on the vitamin B1(+) diet for the
first 10 days but on the vitamin B1() diet for the remaining
21 days, or on the vitamin B1() diet for the first 21 days and
on the vitamin B1(+) diet for the remaining 10 days (Figure 6A).
All groups received oral immunization with cholera toxin (CT) on
days 14 and 21, and feces and mononuclear cells were
collected on day 31 for measurement of IgA antibody produc-
tion against the B subunit of cholera toxin (CTB) by ELISA
and of IgA-antibody forming cells (AFCs) by ELISPOT assays
(Figure 6A).1, October 6, 2015 ª2015 The Authors 127
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Figure 6. Vitamin B1-Mediated Maintenance of Naive B Cells in the PPs Is Required for the Induction Phase but Not the Effector Phase of the
Intestinal IgA Response against Oral Antigen
(A) The experimental schedule is summarized.Mice weremaintained on the vitamin B1(+) diet throughout the 31-day experimental period (group 1); for 10 days on
the vitamin B1(+) diet and then on the vitamin B1() diet for 21 days (group 2); or on the vitamin B1() diet for 21 days and then on the vitamin B1(+) diet for 10 days
(group 3). All groups underwent oral immunization with 10 mg CT on days 14 and 21.
(B and C) On day 21, ELISA (B) and ELISPOT assays (C) were performed to assess CT subunit B (CTB)-specific IgA production and the number of IgA antibody-
forming cells (AFCs), respectively. The data are given as means ± 1 SD (n = 6) and are representative of three independent experiments.
See also Figure S6.After oral immunization with CT, mice maintained on the
vitamin B1(+) diet throughout the 31-day experiment showed
high levels of CTB-specific fecal IgA production as well as
increased numbers of CTB-specific IgA AFCs in the iLP (Figures
6B and 6C). Mice that received the control diet followed by the
deficient diet had normal numbers of naive B cells in the PPs dur-
ing the oral immunization period (days 14 and 21) but decreased
numbers on day 31. In addition, the CTB-specific fecal IgA and
IgA AFCs in the iLP of these mice were similar to those of the
controls (Figures 6B and 6C). In contrast, mice fed the deficient
diet followed by the control diet showed reduced numbers of
naive B cells during the oral immunization period and corre-
spondingly decreased levels of CTB-specific fecal IgA produc-
tion and IgA AFCs in the iLP (Figures 6B and 6C). Similarly, anti-
gen-specific IgG production was decreased in the serum of
vitamin B1() micewhen they underwent intraperitoneal immuni-
zation with ovalbumin plus alum (Figure S6). Taken together,
these results indicate that vitamin B1-mediated maintenance of
naive B cells is required during immunization—but not there-
after—for efficient antibody responses against orally or system-
ically immunized antigens.
DISCUSSION
In this study, we showed the different patterns of energy meta-
bolism between naive B cells and terminally differentiated IgA+
PCs. Our study revealed that IgA+ PCs in the iLP showed higher
expression of glycolysis-related metabolites than did naive B
cells in the PPs. It had been reported that B cell activation by
crosslinking through B cell receptors (BCRs) induced a meta-
bolic shift to the glycolytic pathway in a phosphatidylinositol 3
kinase- and protein kinase Cb-dependent manner; this shift
reportedly was associated with the upregulation of GLUT1 and
the activation of hexokinase and phosphofructokinase, key en-
zymes in glycolysis (Blair et al., 2012; Doughty et al., 2006;
Moon et al., 2011). Similar to that of BCRs, IL-4- and toll-like re-128 Cell Reports 13, 122–131, October 6, 2015 ª2015 The Authorsceptor (TLR)-mediated stimulation likewise induced metabolic
changes in B cells (Dufort et al., 2007; Haimovich et al., 2010).
Because BCRs, TLRs, and IL-4 are prerequisite molecules for
the differentiation of B cells into IgA+ PCs (Kunisawa et al.,
2012b), class switching from IgM to IgA likely is associated
with the metabolic shift toward preferential use of the glycolytic
pathway, allowing IgA+ PCs to respond to the increased energy
demand associated with antibody production. Unlike intestinal
IgA+ PCs, PCs in the systemic immune compartment (e.g.,
spleen) contained few glycolytic metabolites. This difference
may be explained by the unique immunologic environment in
the intestine, where there is continuous exposure to bacterial
products (e.g., LPS) and consequent simultaneous production
of cytokines.
B cell differentiation into PCs is accompanied by increases in
the sizes of cells, ER, and secretory organelles to accommodate
massive secretion of antibody (Manz and Radbruch, 2002), a
process that requires large amounts of amino acids, lipids, and
sugar and increased demand for ATP. Therefore, it is reasonable
that IgA+ PCs exploit a pathway that combines glycolysis and the
TCA cycle to obtain large amounts of ATP and amino acids for
the efficient production of IgA. Glucose-initiated energy genera-
tion is essential for antibody production, according to a recent
study that has demonstrated that B cell-specific deletion of
GLUT1 results in impaired antibody production in vivo (Caro-
Maldonado et al., 2014). In contrast to PCs, naive B cells use
the TCA cycle in isolation from glycolysis. In this regard, it previ-
ously was reported that B cells use glucose-independent gluta-
mine metabolism via the TCA cycle for their survival (Le et al.,
2012). Together with our current finding that glucose wasmetab-
olized into glutamate through the TCA cycle, the cited study may
explain our current findings of increased levels of the glutamine-
derived TCA cycle metabolites, fumarate, and malate in naive B
cells.
Recent studies have disclosed several examples of vitamin-
mediated immune regulation, including lymphocyte trafficking
by vitamins A and D (Mora et al., 2008); T cell differentiation (Hall
et al., 2011), innate lymphoid cell function (Spencer et al., 2014),
and mast cell activation (Kurashima et al., 2014) by vitamin
A; and regulatory T cell survival by vitamin B9 (Kinoshita et al.,
2012; Kunisawa et al., 2012a). In the current study, we
extend our understanding of vitamin-mediated immune regula-
tion by showing the immunologic association between vitamin
B1 and B cell immunometabolism in the intestine. The metabolic
changes during B cell differentiation into IgA+ PCs were accom-
panied by decreased expression of THTR-1 and loss of the
dependency on vitamin B1. A previous study demonstrated
that treatment with high glucose concentrations decreased the
expression of THTR-1 in proximal tubular epithelial cells via the
downregulation of specificity protein 1, a transcription factor of
THTR1 (Larkin et al., 2012). Therefore, the high glucose uptake
of IgA+ PCs may induce the downregulation of THTR1 and
thus independence from vitamin B1.
Vitamin B1 deficiency is rare in developed countries but still
characterizes chronic alcohol abuse and severe malnutrition
(Zahr et al., 2011). In addition, some dietary preservatives
(such as sulfites) (Stammati et al., 1992) and some kinds of
plants, raw fish, shellfish, and bacteria produce thiaminases
that degrade vitamin B1 (Murata, 1982). Furthermore, vitamin
B1 uptake is reduced by thyroid hormone and diabetes (Larkin
et al., 2012). Therefore, aspects that alter the intestinal environ-
ment, such as diet and commensal bacteria, as well as host
intrinsic factors that affect the absorption and cellular uptake
of vitamin B1, affect host immune responses through the regula-
tion of immunometabolism.
EXPERIMENTAL PROCEDURES
Mice
Female Balb/c mice (age, 7 weeks) were purchased from Japan Clea. Vitamin
B1() and control diets composed of chemically defined materials were pur-
chased from Oriental Yeast (Kunisawa et al., 2012a). All animals were main-
tained in the experimental animal facilities of the University of Tokyo and
National Institute of Biomedical Innovation. The experiments were approved
by the Animal Care and Use Committees of both institutes and were conduct-
ed in accordance with their guidelines.
Lymphocyte Isolation
Lymphocyteswere isolated from the spleen, bonemarrow, PPs, and iLPofmice
as previously described (Kunisawa et al., 2013). Briefly, PPs were stirred in
1.6mg/ml collagenase (Wako) to obtain a single-cell suspension. To isolate lym-
phocytes from the iLP, PPs were removed from the intestinal tissue, and the re-
maining intestinal tissuewas rinsed inRPMI 1640medium,cut into 2-cmpieces,
and stirred for 20 min in RPMI 1640 medium containing 1 mM EDTA and 2%
fetal calf serum. The tissue pieces then were stirred for 15 min three times in
0.8 mg/ml collagenase, and the dissociated cells underwent centrifugation
through a discontinuous Percoll (GE Healthcare) gradient. Lymphocytes were
isolated at the interface between the 40% and 75% Percoll layers.
Flow Cytometry and Cell Sorting
A standard protocol was used for cell staining and subsequent flow cytometric
analysis (Kunisawa et al., 2013). Briefly, cells were incubated with 5 mg/ml anti-
CD16/32 antibody (Ab) (Fc Block, Biolegend) for 5 min and stained with fluo-
rescently labeled Abs specific for B220, CD3, CD93, CD138, IgM (Biolegend),
and IgA (BD Biosciences) for 30 min at 4C. The Viaprobe reagent (BD Biosci-
ences) was used to discriminate between dead and live cells. Apoptotic cells
were detected by using the Annexin V Apoptosis Detection kit according to the
manufacturer’s instructions (Biolegend). For BrdU incorporation, mice were in-Cjected intraperitoneally with 1 mg BrdU (Sigma-Aldrich) in PBS as previously
described (Kunisawa et al., 2007, 2013). At the indicated times, mononuclear
cells were isolated from the small intestine and stained with fluorescent IgA-
specific antibodies. BrdU incorporation was detected with a BrdU Flow kit ac-
cording to the manufacturer’s instructions (BD Biosciences). Flow cytometric
analysis and cell sorting were performed by using FACSCanto II and FACSAria
III (BD Biosciences) instruments, respectively.
Histologic Analysis
Immunohistochemical analysis andH&E stainingwere performed aspreviously
described (Kurashima et al., 2014; Obata et al., 2013). Briefly, small intestine
was fixed in 4% paraformaldehyde for 15 hr at 4C and washed and treated
in 20%sucrose for 12 hr at 4C. The tissueswere embedded inOCTcompound
(Sakura Finetechnical). Cryostat sections (7 mm) were preblocked with an anti-
CD16/CD32 Ab (Biolegend) for 15 min at room temperature and stained with
fluorescent-conjugated Abs specific for B220 (Biolegend) or IgA (BD Biosci-
ences). Slides were counterstained by using DAPI (Sigma-Aldrich). For the
detection of THTR1, cryostat sections (7 mm) were fixed with cold acetone for
1 min without paraformaldehyde fixation. THTR1 was detected by using a rab-
bit anti-SLC19A2 (THTR1) polyclonal Ab (Atlas Antibodies) and a Cy3-conju-
gated donkey anti-rabbit IgG Ab (Jackson Immunoresearch Laboratories).
For the detection of CD4, a biotin-conjugated anti-CD4 antibody (BD Biosci-
ences) and a TSA-Direct kit (Perkin-Elmer) were used according to the method
previously described (Obata et al., 2013). The specimens were analyzed by us-
ing a fluorescence microscope (model BZ-9000, Keyence).
MALDI-IMS
MALDI-IMS and CE-MS were performed as previously reported (Kunisawa
et al., 2015; Sugiura et al., 2011). Briefly, frozen tissues were sectioned to a
thickness of 8 mm by using a cryostat (CM 3050, Leica). The frozen sections
were thaw mounted onto indium-tin-oxide (ITO)-coated glass slides (Bruker
Daltonics). MALDI-IMS was performed by using 9-aminoacridine as the matrix
(10 mg/ml, dissolved in 80% ethanol). MALDI imaging was performed by using
an MALDI-TOF mass spectrometer (UltraFlextreme, Bruker Daltonics) equip-
ped with an Nd:YAG laser. Data were acquired in the negative reflectron
mode with raster scanning by a pitch distance of 50 mm. Image reconstruction
was performed by using FlexImaging 4.1 software (Bruker Daltonics).
CE-MS
CE-MSwas performed as previously reported (Sugiura et al., 2011). Frozen tis-
sues or purified cells were homogenized inmethanol (500 ml) by using amanual
homogenizer (Finger Masher [AM79330]; Sarstedt), followed by the addition of
an equal volume of chloroform and 0.4 times the volume of Milli-Q water. After
centrifugation (3 cycles of 60 s each at 4,000 rpm), the aqueous phase was ul-
trafiltered by using an ultrafiltration tube (Ultrafree-MC, UFC3 LCCNB; Human
Metabolome Technologies), and the filtrates were dried. The dried residues
were resuspended in 50 ml of Milli-Q water and were used for CE-MS. All
CE-MS experiments were performed by using an Agilent CE System equipped
with an air pressure pump, an Agilent 6520 Accurate Q-Tof mass spectrom-
eter, an Agilent 1200 series isocratic high-performance LC pump, 7100 CE-
system, a G1603A Agilent CE-MS adaptor kit, and a G1607A Agilent CE-MS
sprayer kit (Agilent Technologies).
Metabolic-Pathway Tracing Analysis Using In Vitro Differentiated
IgA+ Cells
For the differentiation of naive B cells into IgA+ cells, purified naive B cells were
cultured with interleukin-4 (IL-4), IL-5, lipopolysaccharide (LPS), and TGF-b for
4 days and then additionally cultured with IL-6 for 3 days (Gohda et al., 2008).
These in vitro differentiated IgA+ cells and freshly isolated naive B cells were
cultured with 2 mg/ml of 13C-labeled glucose (ISOTEC, Sigma-Aldrich) in
RPMI1640medium (plus 10%FCS and 2-mercaptoethanol, no pyruvate or an-
tibiotics) for 1 hr. After being washed with PBS twice, the cells were used for
the CE-MS analysis.
Measurement of Vitamin B1 Concentration
Vitamin B1 concentration was measured by using VitaFast Vitamin B1 (thia-
mine) (r-Biopharm). Briefly, sample extract was added to Lactobacillusell Reports 13, 122–131, October 6, 2015 ª2015 The Authors 129
fermentum in vitamin B1() medium. The growth of L. fermentum is dependent
on the vitamin B1 concentration of the medium. The vitamin B1 concentration
of the sample was determined by referring to a standard curve.
Measurement of Glucose Uptake, GAPDH, and Succinate
Dehydrogenase Activity
To measure glucose uptake and enzymatic activity of GAPDH and succinate
dehydrogenase, we used the 2-Deoxyglucose Uptake Measurement Kit (Cos-
mobio), KDalert GAPDH Assay Kit (Life Technologies), and MTT Cell Prolifera-
tion Assay kit (Cayman Chemical) according to the manufacturers’ protocols.
Drug Treatment
Purified naive B cells or IgA+ PCs (5 3 104 cells) were cultured with 3 mM oli-
gomycin (Sigma-Aldrich) or 5 mM rotenone (Sigma-Aldrich) for 20 hr. For the
oxythiamine treatment, purified naive B cells or IgA+ PCs (1 3 105 cells)
were cultured with oxythiamine for 3 days. Live cells were counted by using
the trypan blue exclusion assay. For the proliferation assay, purified naive B
cells were stained with 2 mM of carboxyfluorescein succinimidyl ester (Life
Technologies) and then were cultured in the presence of various concentra-
tions of oxythiamine and 10 mg/ml of LPS (O127:B8; Sigma-Aldrich) for 3 days.
Quantitative and Conventional RT-PCR
To measure mRNA expression, qRT-PCR was performed (Kurashima et al.,
2014). Briefly, total RNA was isolated by using TRIzol reagent (Invitrogen),
and cDNA was synthesized by using Powerscript reverse transcriptase (BD
Biosciences). RT-PCR was performed by using LightCycler 480 (Roche Diag-
nostics) with the SYBR Green system. The oligonucleotide primers used in
this study were obtained from Hokkaido System Science and include those
for OGDH (forward primer, 50-ACTGTGCCTGGTTGGAGAATCCC-30; reverse
primer, 50-ACTGCACCGCCAAGTGGTCC-30), Aco2 (forward primer, 50-GCG
CAGGGCCAAGGACATAAA-30; reverse primer, 50-GGGGGTGTGCGAATCA
GTGCC-30), THTR1 (forward primer, 50-CGACAAGAACTTGACCGAGA-30;
reverse primer, 50-AAGGAACACGGGAAACAGC-30), THTR2 (forward primer,
50-CATTGTTGGGTGAATTGGACT-30; reverse primer, 50-GAGTTGCTCGGTG
GAGTTCT-30), and cyclophilin (forward primer, 50-GACGAAGGTAGCCAGT
CACAAG-30; reverse primer, 50-AATCAGGCCTGTGGAATGTGAG-30 ).
Immunization and Detection of Antibody Responses by ELISA and
ELISPOT Assays
For oral immunization on days 14 and 21, mice were given sodium bicarbonate
solution to neutralize stomach acid (Kunisawa et al., 2013, 2014); 30 min later,
the mice were orally immunized with 10 mg of CT (List Biological Laboratories).
At 10 days after the final immunization, fecal samples and mononuclear cells
were collected for measurement of CTB-specific antibody responses by using
ELISA and ELISPOT assays, respectively, as previously described (Kunisawa
et al., 2013). For systemic immunization, mice were maintained on vitamin
B1(+) or vitamin B1() diet. On day 22, mice were injected intraperitoneally
with 100 mg of ovalbumin (OVA) plus alum (Life Technologies) and serum sam-
ples were collected on day 28 for the measurement of OVA-specific IgG by
ELISA.
Statistics
Results were compared by using the nonparametric Mann-Whitney U test and
two-tailed unpaired t test (GraphPad Software).
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